Welcome to our dedicated page for AMEH news (Ticker: AMEH), a resource for investors and traders seeking the latest updates and insights on AMEH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AMEH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AMEH's position in the market.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported strong financial results for Q3 2020, with total revenue reaching $180.1 million, a 15% increase from the previous year. Net income soared 137% to $25.4 million, and net income attributable to ApolloMed increased to $16.7 million. For the nine months ending September 30, 2020, total revenue was $510.4 million, marking a 34% increase year-over-year. The company raised its full-year guidance, now expecting total revenue between $665.0 million and $675.0 million, and adjusted EBITDA between $97.0 million and $112.0 million.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) has announced it will release its consolidated financial results for the third quarter ended September 30, 2020, on November 4, 2020, after market close. The company focuses on integrated population health management, particularly for senior patients and those with chronic conditions, through its various subsidiaries and affiliated organizations. This release is expected to provide insights into ApolloMed's financial performance and strategic initiatives in the healthcare sector.
Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported a strong second quarter for 2020, with total revenue reaching $165.2 million, marking a 27% increase from the previous year. This growth was primarily driven by acquisitions contributing approximately $45 million in revenue. Capitation revenue rose 37% to $140.9 million, representing 85% of total revenue. Net income attributable to ApolloMed was $7.0 million, up from $3.5 million year-over-year. The company maintains guidance for full-year revenue between $665 million and $675 million.